Skip to content
healthcare.dev

Olmesartan Medoxomil and Hydrochlorothiazide

NDC 60290-102, Olmesartan Medoxomil and Hydrochlorothiazide, tablet, from Umedica Laboratories USA Inc..

Product NDC
60290-102
Status
Listed
Labeler
Umedica Laboratories USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208847
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60290-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLMESARTAN MEDOXOMIL20 mg/1
  • HYDROCHLOROTHIAZIDE12.5 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
60290-102-016029001020130 TABLET in 1 BOTTLE (60290-102-01)
60290-102-026029001020290 TABLET in 1 BOTTLE (60290-102-02)
60290-102-0360290010203500 TABLET in 1 BOTTLE (60290-102-03)
60290-102-04602900102041000 TABLET in 1 BOTTLE (60290-102-04)
60290-102-0560290010205100 TABLET in 1 BLISTER PACK (60290-102-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/55d6aee1-01ca-4791-8404-386664b4ab07

Use it

Look up 60290-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60290-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60290-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.